Wells Group - Skin cancer immunotherapy - Grants

If you would like to make a tax deductible donation to skin cancer immunotherapy research, please contact med.advancement@uq.edu.au. Thank you for your support.

We are very grateful to the following current funding sources:

• Preclinical development of Q2361, a transforming new drug for skin cancer prevention in organ transplant recipients

(2021–2023) NHMRC Development Grant

• Donation to support the research of James Wells

(2020–2025) Kyon Biotech AG

• Saving your skin: physiology of immune regulation in mammalian lymph nodes

(2020–2022) ARC Discovery Projects

• Drug discovery to eliminate skin cancers in transplant patients

(2019–2025) Merchant Charitable Foundation

• Development of a novel drug to prevent skin cancer in solid organ transplant recipients

(2019) PA Research Foundation

• Development of a human skin model to assess topical pharmaceutical and complementary and alternative medicine (CAM) toxicity and effects (SCCA grant led by QUT)

(2018–2020) Queensland University of Technology and Skin Cancer College Australasia